special
report
build
expand
knowledg
base
compris
establish
principl
need
assess
box
use
creat
logic
web
futur
plan
use
critic
path
method
assess
valid
specif
diagnost
publish
recent
ebola
viru
diseas
ebola
tabl
theori
spatial
care
path
tm
scp
describ
recent
kost
et
al
pivot
advantag
pointofcar
test
poct
diagnosi
triag
monitor
recoveri
derisk
stop
outbreak
real
sens
urgenc
highli
infecti
diseas
outbreak
emerg
threaten
world
map
futur
extrapol
stopgap
emerg
use
author
eua
ebola
middl
east
respiratori
syndrom
coronaviru
merscov
detect
issu
fda
usa
onward
futur
sustain
poc
molecular
diagnost
could
use
facilitatedaccess
selftest
point
care
fast
poc
tm
new
solut
enhanc
resili
communitybas
strategi
fill
gap
need
order
local
popul
cluster
peopl
respond
extern
intern
threat
old
new
often
unpredict
infecti
diseas
box
extens
formal
need
assess
survey
defin
specif
name
high
sensit
safeti
user
friendli
portabl
molecular
pathogen
detect
biohazard
contain
urgent
call
publish
accept
criteria
prioriti
featur
ebola
diagnost
target
product
profil
tabl
featur
compris
high
clinic
sensit
first
day
patient
present
desir
accept
extrem
high
analyt
specif
desir
accept
box
need
assess
principl
develop
pointofcar
diagnost
develop
logic
model
systemat
pursuit
project
goal
timelin
effici
clearli
identifi
goal
object
term
need
assess
survey
assess
result
alreadi
publish
previou
survey
design
survey
eg
observ
intervent
epidemiolog
secur
ethic
approv
appropri
administr
level
andor
local
draw
respond
randomli
geograph
dispers
site
welldefin
expert
profession
layperson
focu
group
avoid
survey
special
interest
group
later
court
law
legal
bodi
may
deem
hearsay
repres
randomli
sampl
larger
popul
therefor
invalid
perform
survey
adequ
breadth
depth
sampl
size
yield
signific
comparison
predefin
variabl
comprehens
balanc
closedand
openend
question
achiev
adequ
respons
rate
use
facil
media
eg
surveymonkey
person
interview
repetit
encourag
followup
commun
appropri
incent
use
origin
method
tradeoff
question
statist
valid
result
base
claim
comparison
p
valu
consid
broader
context
nation
polici
guidelin
costeffect
market
sustain
simultan
target
outcom
peopl
want
busi
realiti
technic
feasibl
integr
smallworld
network
analysi
consider
disast
emerg
outbreak
public
health
resili
specif
present
seriou
challeng
technolog
design
implicit
low
cost
howev
global
field
experi
shown
costeffect
attain
assess
overal
valu
poc
diagnost
cost
despit
practic
challeng
econom
realiti
enabl
appropri
valu
proposit
also
target
popul
patient
present
fever
health
care
facil
assess
miss
point
seriou
error
stop
outbreak
poc
detect
substanti
upstream
first
point
contact
sick
febril
patient
spread
diseas
other
first
point
contact
anywher
poct
use
concept
wait
patient
present
fever
far
downstream
scp
therefor
late
stop
outbreak
addit
featur
includ
effici
process
step
perform
oper
desir
accept
time
step
respect
facilit
transfer
precis
volum
sampl
quick
analysi
min
desir
h
accept
intern
control
autom
sampl
prepar
sever
delin
oper
characterist
robust
oper
condit
c
desir
c
accept
rel
humid
durabl
reagent
minim
train
requir
temperatur
specif
c
may
encount
bubbl
format
reagent
cassett
physic
alter
sampl
temperatur
control
diagnost
center
although
limitedresourc
set
challeng
format
small
handheld
kg
desir
tabletop
accept
portabl
instrument
min
time
limit
use
open
reagent
ideal
solar
altern
recharg
batteri
power
oper
h
wellconfigur
portabl
robust
ergonom
poc
devic
would
ideal
isol
area
altern
care
facil
mobil
venu
field
pointofcar
test
isol
area
tabl
list
poct
select
special
isol
area
emori
univers
hospit
use
biocontain
unit
univers
nebraska
medic
center
design
ebola
contain
center
suit
addit
poc
test
cluster
select
reader
web
sourc
list
clinic
laboratori
improv
actwaiv
poc
test
simplest
use
one
awar
test
fda
clear
use
critic
ill
patient
import
consider
ebola
patient
identifi
cluster
test
fulfil
need
costeffect
ideal
instrument
possibl
poc
staff
poc
devic
oper
must
train
use
person
protect
equip
sampl
handl
procedur
care
patient
ebola
research
innov
novel
technolog
surfac
acoust
wave
detect
recombinas
polymeras
amplif
panel
multicolor
silver
nanoparticl
manufactur
encourag
respond
threat
futur
outbreak
produc
userfriendli
poc
cassettescartridg
cuvett
multiplex
test
cluster
design
specif
ebola
patient
ebola
test
cluster
exampl
coagul
test
handheld
devic
clear
fda
anticoagul
warfarin
monitor
diagnos
dissemin
intravascular
coagul
one
seriou
complic
ebola
clearli
gap
need
close
improv
surviv
assum
suitabl
therapi
avail
ebola
patient
develop
rampant
bleed
septic
shock
multiorgan
failur
acut
hepat
necrosi
lead
fatal
outcom
saijo
et
al
review
laboratori
diagnost
ebola
marburg
hemorrhag
fever
nearli
decad
later
fda
acceler
ongo
develop
valid
approv
new
diagnost
test
ebola
issu
eua
less
continu
sinc
fall
tabl
present
eua
chronolog
order
respect
method
statu
develop
ebolaspecif
challeng
molecular
diagnost
includ
reduct
initi
fals
neg
fn
fn
function
time
ramp
sensit
tp
tp
fn
ultrahigh
level
infect
patient
first
h
symptom
may
mild
absent
order
avoid
shunt
falseneg
case
commun
hospit
ill
prepar
receiv
highrisk
patient
tp
true
posit
ii
autom
total
selfcontain
sealabl
specimen
cassett
cartridg
elimin
need
expens
high
level
biosafeti
cabinet
iii
proof
effect
control
intern
contamin
portabl
instrument
therebi
sustain
ultrahigh
specif
tn
tn
fp
minim
fals
posit
place
peopl
risk
near
infect
patient
tn
true
neg
fp
fals
posit
sophist
compact
technolog
becom
avail
iv
determin
quantit
viral
genom
titer
use
earli
detect
exposur
small
volum
specimen
also
deescal
level
care
quarantin
patient
improv
perform
properli
biohazard
precaut
nearpati
test
area
diagnost
center
result
avail
much
quickli
send
specimen
public
health
laboratori
cdc
gain
time
substanti
less
h
need
obtain
answer
see
tabl
facilit
rapid
screen
focus
triag
effect
workflow
west
africa
practic
effici
help
offset
profession
shortag
countri
larg
number
peopl
per
physician
liberia
fatal
rate
sierra
leon
box
intern
threat
highli
infecti
diseas
demograph
incid
secreci
commun
risk
usa
high
contain
laboratori
oper
govern
agenc
univers
privat
compani
scatter
throughout
usa
district
columbia
experi
underway
involv
drugresist
tb
plagu
anthrax
botul
ricin
exot
flu
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
ebola
marburg
hemorrhag
fever
virus
laboratori
experi
potenti
bioterror
agent
cite
regul
cdc
usda
seriou
safeti
secur
fail
face
sanction
accord
limit
inform
releas
freedom
inform
act
laboratori
notifi
feder
regul
incid
worker
receiv
medic
treatment
evalu
peopl
contract
laboratoryacquir
infect
anim
also
becam
infect
laboratori
refer
potenti
enforc
action
fine
levi
total
million
addit
laboratori
place
perform
improv
plan
scrutini
select
agent
perform
bar
use
select
agent
multipl
enforc
action
expel
accid
last
year
compromis
secur
ebola
avian
influenza
smallpox
nih
cdc
collect
flu
virus
engin
contagi
found
natur
far
accident
outbreak
report
ident
affili
locat
laboratori
complianc
kept
secret
bioterror
law
even
name
two
laboratori
expel
reveal
public
publicli
avail
list
high
contain
laboratori
research
activ
scope
research
safeti
record
larg
unknown
state
offici
charg
protect
public
health
commun
risk
oversight
fragment
selfpol
margin
effect
view
hundr
safeti
accid
laboratori
nationwid
deliber
theft
misus
deadli
pathogen
releas
virus
bacteria
toxin
accident
intent
outbreak
lack
transpar
resid
live
near
biolab
repres
sourc
mistrust
frustrat
commun
risk
inform
new
public
health
framework
special
report
informahealthcarecom
guinea
last
fall
urgent
plead
rapid
diagnost
meet
need
help
make
shortfal
even
physician
nurs
west
africa
contract
ebola
die
selfcontain
cartridgecassettebas
rapid
molecular
test
avail
small
portabl
platform
test
infecti
diseas
develop
poc
molecular
diagnost
highrisk
infecti
diseas
see
tabl
forecast
feasibl
introduc
ebola
assay
lightweight
platform
like
aler
figur
tini
roch
diagnost
coba
liat
figur
clinic
laboratori
improv
actwaiv
test
satisfi
certain
condit
waiv
clear
fda
use
clinic
home
simpl
carri
use
operatorfriendli
equip
improv
chanc
accur
test
result
see
potenti
solut
emerg
fast
poc
tm
industri
move
forward
chronolog
progress
ebola
euasinexpens
portabl
safe
appropri
detect
virus
earli
stage
clinic
ill
facilitatedaccess
selftest
point
care
fast
poc
tm
mean
patient
obtain
capillari
blood
sampl
automat
retract
lancet
sampl
devic
built
selfaspir
selfcontain
microcassettemicrocuvettecartridg
seal
autom
process
automat
test
integr
poc
instrument
schemat
illustr
floor
plan
compon
design
newli
creat
diagnost
center
left
area
neg
pressur
temperatur
c
rel
humid
clean
room
class
right
shower
room
chang
room
posit
pressur
latter
interlock
anteroom
top
left
inset
show
poct
biosafeti
cabinet
refer
text
test
cluster
test
menu
specimen
prepar
rout
pass
box
shown
along
bottom
ppe
use
se
asia
right
staff
circul
clockwis
ppe
perform
work
doff
ppe
exit
avoid
exposur
contamin
diagnost
center
deploy
bangkok
thailand
could
mobil
vehicl
move
hotspot
break
log
jam
slow
test
tier
frontlin
assess
treatment
approach
anoth
person
facilit
instruct
guid
hand
extrem
limit
exposur
infecti
agent
technolog
develop
poct
indic
fast
poc
tm
becom
realiti
complement
poc
cultur
well
like
someth
hidden
plain
view
fast
poc
tm
offer
cultur
adapt
solut
new
public
health
framework
special
report
informahealthcarecom
stop
futur
outbreak
whether
ebola
merscov
novel
new
threat
minim
signific
exposur
other
oneself
infect
patient
henc
littl
risk
similar
selfmonitor
blood
glucos
individu
diabet
famili
member
instruct
home
obtain
result
without
actual
contact
blood
specimen
test
compon
altern
visit
local
public
health
worker
educ
instruct
guid
facilit
selftest
primari
care
site
without
necessarili
touch
patient
assay
compon
fast
poc
tm
help
elimin
fear
go
treatment
center
separ
famili
assign
love
one
lone
death
may
dengu
hepat
hiv
influenza
malaria
syphili
tuberculosi
common
diseas
limitedresourc
set
elsewher
ebola
merscov
west
africa
fast
poc
tm
enabl
primari
care
site
clinic
treatment
center
sought
site
speedi
diagnosi
excel
care
improv
chanc
surviv
poct
improv
global
health
global
health
problem
ebola
propel
poct
urgent
implement
worldwid
need
clear
document
sever
survey
worldwid
addit
recent
revel
accid
secreci
advers
outcom
highli
infecti
diseas
made
public
investig
journalist
highlight
potenti
outbreak
local
usa
commun
world
financi
loss
ebola
outbreak
warrant
invest
direct
vaccin
also
develop
poc
molecular
diagnost
preced
poc
diagnost
avail
upstream
immigr
screen
cruis
ship
industri
site
abroad
point
first
encount
worldwid
companion
diagnost
coagulopathi
test
cluster
ptinr
prothrombin
timeintern
normal
ratio
ddimer
fibrinogen
platelet
viral
load
assay
digit
pcr
streamlin
therapeut
monitor
downstream
scp
consolid
process
step
ultim
help
stop
spread
outbreak
diagnost
center
control
environment
condit
place
along
scp
motiv
industri
respond
call
robust
diagnost
test
consolid
commun
effort
costeffect
broader
scale
construct
approxim
special
isol
unit
hong
kong
motiv
histor
death
patient
healthcar
worker
sever
acut
respiratori
syndrom
infect
kill
peopl
avian
influenza
guangzhou
china
sever
acut
respiratori
syndrom
kill
disast
repeat
usa
vulner
unend
seri
threat
threat
includ
one
abroad
also
within
document
box
recent
journalist
research
reveal
shock
nondisclosur
commun
risk
adapt
se
asia
individu
usa
hospit
isol
area
atlanta
dalla
new
york
bethesda
nih
clinic
center
omaha
notabl
yet
gener
isol
bed
capac
adequ
experi
quickli
enough
deal
potenti
larg
number
case
infecti
diseas
outbreak
futur
cdcapprov
hospit
treatment
center
distribut
unevenli
recent
launch
fund
nation
ebola
train
educ
center
cdc
health
human
servic
offic
assist
secretari
prepared
respons
compris
emori
univers
medic
center
atlanta
georgia
univers
nebraska
medic
center
omaha
nebraska
bellevu
hospit
center
new
york
citi
facilit
develop
addit
treatment
center
nine
current
treatment
center
enhanc
capabl
altern
care
facil
diagnost
center
integr
logist
commun
smallworld
network
cdc
recommend
engag
allow
usa
commun
respond
effici
effect
special
report
kost
ferguson
truong
et
al
regard
intern
threat
govern
academia
privat
compani
must
disclos
inform
problem
occur
secur
biolab
commun
set
medic
financi
public
health
prioriti
peopl
right
know
safeti
violat
occur
fact
layperson
given
weight
oversight
committe
extern
threat
ebola
new
infecti
diseas
threat
strateg
planer
must
reshap
public
health
resili
point
need
june
merscov
feasibl
rapid
poc
molecular
diagnost
one
fda
eua
exist
vaccin
definit
treatment
spread
throughout
south
korea
place
quarantin
remain
hospit
second
quarter
south
korean
growth
worst
year
govern
announc
stimulu
packag
econom
growth
forecast
cut
henc
predict
heavi
econom
impact
futur
threat
asean
countri
merscov
suspect
health
care
worker
treat
first
patient
isol
infect
peopl
occupi
room
first
patient
other
ward
time
rang
min
sever
hour
said
prime
minist
park
geunhy
insuffici
initi
respons
includ
judgment
contagi
mani
time
scenario
repeat
econom
medic
cost
respons
properli
strateg
restructur
enabl
point
first
contact
need
care
therefor
summari
recommend
acceler
proactiv
plan
nation
prepared
develop
new
poc
technolog
especi
field
evalu
case
ebola
demonstr
high
sensit
interest
poc
result
clinic
set
futur
paradigm
poc
diagnost
think
global
act
global
test
local
peopl
context
cultur
set
intrins
emerg
poc
cultur
popular
expect
rapid
diagnosi
highrisk
virus
use
dispos
test
strip
selfcontain
autom
technolog
mobil
cartridg
cassetteor
cuvettebas
approach
diagnost
properli
fulfil
expect
popular
expect
key
motiv
next
year
deliv
ultrahigh
sensit
specif
predict
valu
help
stifl
outbreak
usa
countri
succumb
futur
threat
untoward
econom
loss
multiplex
pcr
assay
particularli
benefici
case
sampl
difficult
collect
short
volum
differ
pathogen
creat
clinic
constel
symptom
sign
addit
instant
traceabl
infect
potenti
infect
individu
know
multiplex
result
locat
movement
time
across
border
help
contain
spread
highli
contagi
diseas
fast
poc
tm
selfknowledg
enabl
peopl
take
ownership
person
diagnost
test
interrupt
rapid
spread
outbreak
impact
shift
public
health
immedi
diagnosi
point
need
new
poc
cultur
public
health
devic
must
compli
jurisdict
regul
specif
countri
oper
use
limit
base
patient
condit
feder
state
legal
statut
hospit
accredit
requir
poc
devic
present
articl
fda
clear
use
usa
fda
emerg
use
author
limit
scope
term
pleas
check
manufactur
current
statu
ebola
merscov
threat
detect
diagnost
poc
test
within
relev
domain
use
zoonot
reservoir
sustain
major
viru
threat
enabl
jump
human
although
vaccin
provid
protect
anim
reservoir
gener
elimin
rapid
detect
high
moral
diseas
point
need
necessari
stop
new
outbreak
facilitatedaccess
selftest
point
care
fast
poc
tm
enabl
type
resolut
detect
occur
upstream
earli
spatial
care
path
home
use
fast
poc
tm
primari
care
site
eg
clinic
emerg
room
prevent
spread
like
occur
merscov
south
korea
patient
dissemin
diseas
throughout
commun
particular
wait
symptomat
patient
present
treatment
center
perpetu
outbreak
unnecessari
mortal
valu
proposit
earli
rapid
diagnosi
formul
context
extraordinari
financi
loss
eg
billion
dollar
lost
west
africa
incur
whole
nation
afflict
epidem
order
assess
costeffect
return
invest
pointofcar
test
recent
ebola
merscov
outbreak
motiv
signific
rethink
ideal
manifest
nation
polici
poc
test
appropri
infrastructur
design
fund
distribut
evenli
geograph
public
health
practition
cdc
organ
anticip
point
first
critic
need
assimil
poc
knowhow
technolog
molecular
diagnost
mobil
test
order
acquir
knowledg
base
sensit
specif
predict
valu
epidem
underway
data
facilit
realworld
diagnost
devic
assay
matur
refin
evidencebas
medicin
target
diseas
prepar
first
respond
futur
outbreak
pointofcar
instrument
expert
profession
certifi
poc
coordin
geospati
scientist
design
spatial
care
path
contribut
collabor
leadership
develop
cohes
nation
strategi
transform
public
health
must
occur
educ
deep
understand
pointofcar
test
profession
integr
teamwork
stop
futur
outbreak
quickli
futur
demand
redefinit
prepared
current
public
health
practic
ultim
commun
worldwid
would
wise
develop
altern
care
site
equip
poc
test
diagnost
center
order
enhanc
resili
event
widespread
outbreak
requir
quarantin
larg
group
peopl
part
order
amelior
civil
right
issu
provid
well
thought
equit
care
paper
special
note
highlight
interest
consider
interest
